Welcome to our dedicated page for Cycurion SEC filings (Ticker: CYCU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cycurion, Inc. filings document material-event disclosures for an emerging growth company operating in AI-driven cybersecurity and information technology services. Recent 8-K reports furnish press releases and exhibits covering customer contract awards, operating and financial updates, shareholder communications, acquisition-related disclosures, legal proceedings, and other corporate events.
The company's regulatory record also includes governance disclosures such as board changes, amendments to prior 8-K reports, capital-structure references involving common stock and warrants, and securityholder-facing information tied to its public-company status. These filings frame Cycurion's contract-based revenue model, cybersecurity platforms, legal matters, and corporate actions in formal SEC disclosure.
Cycurion, Inc. filed an 8-K stating it was selected as an approved vendor under the Florida State Term Contract for Information Technology Staff Augmentation Services. The company disclosed this under Item 8.01 and furnished a press release as Exhibit 99.1 dated October 29, 2025. This designation allows Cycurion to be eligible for staff augmentation opportunities within Florida’s statewide IT procurement framework, as outlined in the announcement.
Cycurion, Inc. implemented a one-for-thirty reverse stock split effective October 27, 2025. The company’s common shares began trading on a split-adjusted basis on the Nasdaq Global Market under the existing ticker CYCU, with a new CUSIP 95758L305.
Every thirty issued shares were combined into one, with no change to par value or the total authorized common shares. Outstanding common shares decreased from approximately 86,533,435 to approximately 2,884,447. Fractional shares will not be issued; holders entitled to a fraction will receive cash based on the closing price on the trading day immediately before the effective date.
The company also disclosed it requested a hearing before a Nasdaq Hearings Panel to appeal a delisting determination, with the hearing scheduled for November 20, 2025.
Cycurion, Inc. approved and implemented a 1-for-30 reverse stock split of its common stock. The action becomes effective with the commencement of business on October 27, 2025, and the shares will begin trading on a split-adjusted basis on The Nasdaq Global Market under the symbol CYCU.
Every thirty issued shares will be combined into one share without changing the par value or the total number of authorized common shares. The number of outstanding common shares will be reduced from approximately 86,533,435 to approximately 2,884,447. No fractional shares will be issued; holders entitled to a fraction will receive a cash payment based on the closing price on the trading day immediately preceding the effective date. Proportionate adjustments will be made to outstanding warrants, option exercise prices and share amounts, and restricted stock awards. The new CUSIP for the common stock will be 95758L305.
Cycurion, Inc. (CYCU) reported a Nasdaq delisting determination and filed an appeal. The company received notice on October 14, 2025 that its common stock is subject to delisting from the Nasdaq Global Market after failing to regain compliance with the $1.00 bid price rule. Cycurion submitted an appeal on October 20, 2025, which stays any suspension and Form 25-NSE filing pending a panel decision, with hearings typically set 30–45 days after the request.
To address the bid-price deficiency, the board approved a 30:1 reverse stock split expected to take effect on October 27, 2025, following prior stockholder approval of a reverse-split range. The company also announced five new contracts totaling approximately $1 million, expected to add $75,000 in monthly recurring revenue. If the appeal is unsuccessful, the shares may move to the over-the-counter market, which the company notes is a more limited and less liquid trading venue and could pressure the stock price.
Cycurion, Inc. reported that its board of directors has waived the lock-up restrictions on its Series A Convertible Preferred Stock. These preferred shares, and the securities issuable upon conversion, had been subject to a one-year lock-up starting from the February 14, 2025 closing of the business combination with Western Acquisition Ventures Corp.
The original terms allowed an early release after six months only if the daily trading value of Cycurion common stock exceeded $150,000 for 30 consecutive trading days and the 30-day volume-weighted average price was above $5.00. Because these trading conditions have not been met, the lock-up would have otherwise remained in place.
The board determined it was in the company’s best interests to waive the restrictions because the Series A Convertible Preferred Stock accrues approximately $120,000 per year in stock or cash payments. If holders convert their preferred shares into common stock, Cycurion could avoid about $120,000 in annual costs, which the company describes as part of a strategic recapitalization to strengthen its balance sheet and support growth initiatives.